Welcome to the OHSU Center For Regenerative Medicine

The OHSU Center for Regenerative Medicine investigates the use of cell therapeutics and novel biomaterials for the treatment of diseases and injuries. Focusing on translational research, researchers at the Center for Regenerative Medicine work to translate therapeutics from the lab bench to the hospital and battlefield, bringing cutting edge therapies and treatments into the hands of physicians and their patients.  Follow the link to read center director Dr. Kenton Gregory's full message. 

 

Collaboration Between HemCon and OHSU is Awarded NIH Grant for the Development of a Transurethral Hemostatic Device 

Center Scientist Dr. Hua Xie will serve as the Co-Primary Investigator in the newly announced collaborative study with Portland-based HemCon Medical Technologies, Inc. (HemCon) to develop a novel chitosan endoluminal hemostatic device to control and prevent prostatic bleeding during prostatic surgery such as transurethral resection of the prostate (TURP).  The device will enable rapid control of bleeding, reduce discomfort associated with extended catheterization, and more significantly enable reduction in hospital stays and expenditure. The OHSU Center for Regenerative Medicine will receive funding as a subcontractor on the NIH Grant.  The official announcement can be found here

 

Vatheuer Family Foundation Announces Continuing Partnership with the OHSU Center for Regenerative Medicine

The generous support of of the Vatheuer Family Foundation is a powerful vote of confidence in the promising regenerative therapies being explored at the CRM.  It helps to assure we may continue to produce cutting edge research in the field.  More can be learned about our partnership on the Vatheuer Family Foundation Website